ADCY1 and Familial prostate cancer: More importantly, the functional involvement of cAMP was confirmed by the demonstration that treatment of prostate cancer cells with MDL-12330A, a potent inhibitor of adenylate cyclase, abolished the promotion of NED by high cell density.